Assessment of Walking-related Fatigability in Patients With Multiple Sclerosis.
Launched by HASSELT UNIVERSITY · Feb 28, 2019
Trial Information
Current as of August 27, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 18 - 70 years
- • Confirmed diagnosis according to the McDonald criteria
- • Performed a 6MWT before, to ensure familiarization
- • Able to walk independently or with unilateral support for 6 minutes without rest
- • Signed the informed consent
- Exclusion Criteria:
- • Exacerbation or relapse within last 3 months before study
- • Other neurological diagnosis, such as stroke and Parkinson
- • MS-like syndromes, such as neuromyelitis optica
- • Other medical condition interfering with walking ability (e.g. cardiac or respiratory diseases, arthritis and fibromyalgia)
About Hasselt University
Hasselt University is a prestigious research institution located in Belgium, renowned for its commitment to advancing scientific knowledge and innovation. With a strong focus on interdisciplinary research, the university actively engages in clinical trials that aim to address pressing health challenges. Leveraging a robust network of collaborations with healthcare professionals, industry partners, and research organizations, Hasselt University strives to translate research findings into practical applications that benefit patient care and public health. The institution is dedicated to maintaining the highest ethical standards and regulatory compliance in all its clinical research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Diepenbeek, , Belgium
Overpelt, , Belgium
Melsbroek, , Belgium
Patients applied
Trial Officials
Peter Feys, prof. dr.
Principal Investigator
Hasselt University
Fanny Van Geel, drs.
Study Chair
Hasselt University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials